BioAge Labs | SC 13G: Statement of acquisition of beneficial ownership by individuals-VK Services, LLC(5.0%),Vinod Khosla(5.0%), etc.
BioAge Labs | SC 13G: Statement of acquisition of beneficial ownership by individuals-Kristen Fortney(6.6%)
BioAge Labs | 10-Q: Quarterly report
BioAge Labs | 8-K: BioAge Labs Reports Third Quarter 2024 Financial Results and Provides Business Updates
BioAge Labs | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(6.2%),Peter Kolchinsky(6.2%), etc.
BioAge Labs | SC 13D: Statement of acquisition of beneficial ownership by individuals-Marc Andreessen(9.0%),Benjamin Horowitz(9.0%), etc.
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director Pande Vijay Satyanand
BioAge Labs | 4: Statement of changes in beneficial ownership of securities- Cormorant Asset Management, LP
BioAge Labs | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. James I. Healy (“Healy”)(6.7%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(6.5%), etc.
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director Pande Vijay Satyanand
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Officer Fortney Kristen
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director ENRIGHT PATRICK G
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director Hemrajani Rekha
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director HEALY JAMES
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director Davidson Michael H.
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Officer Morgen Eric
BioAge Labs | 4: Statement of changes in beneficial ownership of securities-Director GARNIER JEAN PIERRE
BioAge Labs | 8-K: Current report
BioAge Labs | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
BioAge Labs | 424B4: Prospectus